miRNAs in the pathogenesis of systemic lupus erythematosus

International Journal of Molecular Sciences

Volumn 16, Issue 5, 2015, Pages 9557-9572

  Qu, Bo ^a   Shen, Nan ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adaptive immunity; Biomarker; Innate immunity; Lupus nephritis; MicroRNA; Systemic lupus erythematosus; Therapy

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MESSENGER RNA; MICRORNA; MICRORNA 125A; MICRORNA 126; MICRORNA 142 3P 5P; MICRORNA 146A; MICRORNA 148A; MICRORNA 150; MICRORNA 155; MICRORNA 17 92; MICRORNA 21; MICRORNA 23B; MICRORNA 29B; MICRORNA 30A; MICRORNA 31; MICRORNA 3148; MICRORNA LET 7A; MICRORNA LET 7C; MYCOPHENOLATE MOFETIL; RANTES; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; UNTRANSLATED RNA;

ADAPTIVE IMMUNITY; BIOGENESIS; CLINICAL TRIAL (TOPIC); GENE EXPRESSION; GENETIC REGULATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MOUSE; PATHOLOGY;

CAENORHABDITIS ELEGANS; MAMMALIA;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, NUCLEAR; AUTOANTIBODIES; BIOMARKERS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICRORNAS; RNA, MESSENGER; RNA, UNTRANSLATED;

EID: 84929334245     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16059557     Document Type: Review

References (115)

1. Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J.L.; Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14, 1902–1910.
2. Lee, Y.; Jeon, K.; Lee, J.-T.; Kim, S.; Kim, V.N. MicroRNA maturation: Stepwise processing and subcellular localization. EMBO J. 2002, 21, 4663–4670.
3. Kim, V.N.; Han, J.; Siomi, M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10, 126–139.
4. Borchert, G.M.; Lanier, W.; Davidson, B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 13, 1097–1101.
5. Lee, Y.; Kim, M.; Han, J.; Yeom, K.H.; Lee, S.; Baek, S.H.; Kim, V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23, 4051–4060.
6. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim, J.; Lee, J.; Provost, P.; Radmark, O.; Kim, S.; et al. The nuclear rnase III Drosha initiates microRNA processing. Nature 2003, 425, 415–419.
7. Yi, R.; Qin, Y.; Macara, I.G.; Cullen, B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17, 3011–3016.
8. Winter, J.; Jung, S.; Keller, S.; Gregory, R.I.; Diederichs, S. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11, 228–234.
9. Khvorova, A.; Reynolds, A.; Jayasena, S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115, 209–216.
10. Yang, J.-S.; Phillips, M.D.; Betel, D.; Mu, P.; Ventura, A.; Siepel, A.C.; Chen, K.C.; Lai, E.C. Widespread regulatory activity of vertebrate microRNA* species. RNA 2011, 17, 312–326.
11. Okamura, K.; Phillips, M.D.; Tyler, D.M.; Duan, H.; Chou, Y.-T.; Lai, E.C. The regulatory activity of microRNA* species has substantial influence on microRNA and 3' UTR evolution. Nat. Struct. Mol. Biol. 2008, 15, 354–363.
12. Kozomara, A.; Griffiths-Jones, S. Mirbase: Annotating high confidence micrornas using deep sequencing data. Nucleic Acids Res. 2014, 42, D68–D73.
13. Krol, J.; Loedige, I.; Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11, 597–610.
14. Davis-Dusenbery, B.N.; Hata, A. Mechanisms of control of microRNA biogenesis. J. Biochem. 2010, 148, 381–392.
15. Han, J.; Lee, Y.; Yeom, K.-H.; Nam, J.-W.; Heo, I.; Rhee, J.-K.; Sohn, S.Y.; Cho, Y.; Zhang, B.-T.; Kim, V.N. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006, 125, 887–901.
16. Gregory, R.I.; Yan, K.-P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432, 235–240.
17. Lee, H.Y.; Zhou, K.; Smith, A.M.; Noland, C.L.; Doudna, J.A. Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing. Nucleic Acids Res. 2013, 41, 6568–6576.
18. Lee, S.H.; Cho, S.; Sun Kim, M.; Choi, K.; Cho, J.Y.; Gwak, H.S.; Kim, Y.J.; Yoo, H.; Lee, S.H.; Park, J.B.; et al. The ubiquitin ligase human TRIM71 regulates let-7 microRNA biogenesis via modulation of Lin28B protein. Biochim. Biophys. Acta 2014, 1839, 374–386.
19. Heo, I.; Joo, C.; Kim, Y.-K.; Ha, M.; Yoon, M.-J.; Cho, J.; Yeom, K.-H.; Han, J.; Kim, V.N. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 2009, 138, 696–708.
20. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215–233.
21. Shin, C.; Nam, J.-W.; Farh, K.K.-H.; Chiang, H.R.; Shkumatava, A.; Bartel, D.P. Expanding the microRNA targeting code: Functional sites with centered pairing. Mol. Cell 2010, 38, 789–802.
22. Bhattacharyya, S.N.; Habermacher, R.; Martine, U.; Closs, E.I.; Filipowicz, W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125, 1111–1124.
23. Kedde, M.; Strasser, M.J.; Boldajipour, B.; Vrielink, J.A.F.O.; Slanchev, K.; le Sage, C.; Nagel, R.; Voorhoeve, P.M.; van Duijse, J.; Ørom, U.A., et al. RNA-binding protein DND1 inhibits microRNA access to target mRNA. Cell 2007, 131, 1273–1286.
24. Memczak, S.; Jens, M.; Elefsinioti, A.; Torti, F.; Krueger, J.; Rybak, A.; Maier, L.; Mackowiak, S.D.; Gregersen, L.H.; Munschauer, M., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013, 495, 333–338.
25. Rybak, A.; Fuchs, H.; Hadian, K.; Smirnova, L.; Wulczyn, E.A.; Michel, G.; Nitsch, R.; Krappmann, D.; Wulczyn, F.G. The let-7 target gene mouse Lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2. Nat. Cell Biol. 2009, 11, 1411–1420.
26. Gargalionis, A.N.; Basdra, E.K. Insights in microRNAs biology. Curr. Top. Med. Chem. 2013, 13, 1493–1502.
27. Xiao, C.C.; Rajewsky, K. MicroRNA control in the immune system: Basic principles. Cell 2009, 136, 26–36.
28. Croce, C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10, 704–714.
29. Condorelli, G.; Latronico, M.V.; Cavarretta, E. MicroRNAs in cardiovascular diseases: Current knowledge and the road ahead. J. Am. Coll. Cardiol. 2014, 63, 2177–2187.
30. Pauley, K.M.; Cha, S.; Chan, E.K. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 2009, 32, 189–194.
31. Bhanji, R.A.; Eystathioy, T.; Chan, E.K.; Bloch, D.B.; Fritzler, M.J. Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin. Immunol. 2007, 125, 247–256.
32. Jakymiw, A.; Ikeda, K.; Fritzler, M.J.; Reeves, W.H.; Satoh, M.; Chan, E.K. Autoimmune targeting of key components of RNA interference. Arthritis Res. Ther. 2006, 8, doi:10.1186/ar1959.
33. Dai, Y.; Huang, Y.S.; Tang, M.; Lv, T.Y.; Hu, C.X.; Tan, Y.H.; Xu, Z.M.; Yin, Y.B. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16, 939–946.
34. Dai, R.; Zhang, Y.; Khan, D.; Heid, B.; Caudell, D.; Crasta, O.; Ahmed, S.A. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS ONE 2010, 5, e14302.
35. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783–801.
36. Lamkanfi, M.; Dixit, V.M. Inflammasomes and their roles in health and disease. Ann. Rev. Cell Dev. Biol. 2012, 28, 137–161.
37. Kawai, T.; Akira, S. The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors. Nat. Immunol. 2010, 11, 373–384.
38. Barber, G.N. Innate immune DNA sensing pathways: Sting, aimii and the regulation of interferon production and inflammatory responses. Curr. Opin. Immunol. 2011, 23, 10–20.
39. Medzhitov, R.; Janeway, C.A., Jr. Innate immunity: Impact on the adaptive immune response. Curr. Opin. Immunol. 1997, 9, 4–9.
40. Rifkin, I.R.; Leadbetter, E.A.; Busconi, L.; Viglianti, G.; Marshak-Rothstein, A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 2005, 204, 27–42.
41. Leadbetter, E.A.; Rifkin, I.R.; Hohlbaum, A.M.; Beaudette, B.C.; Shlomchik, M.J.; Marshak-Rothstein, A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 2002, 416, 603–607.
42. Anders, H.-J.; Vielhauer, V.; Eis, V.; Linde, Y.; Kretzler, M.; Perez de Lema, G.; Strutz, F.; Bauer, S.; Rutz, M.; Wagner, H., et al. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 2004, 19, 534–536.
43. Banchereau, J.; Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25, 383–392.
44. Baccala, R.; Hoebe, K.; Kono, D.H.; Beutler, B.; Theofilopoulos, A.N. TLR-dependent and TLR-independent pathways of type i interferon induction in systemic autoimmunity. Nat. Med. 2007, 13, 543–551.
45. Shrivastav, M.; Niewold, T.B. Nucleic acid sensors and type I interferon production in systemic lupus erythematosus. Front. Immunol. 2013, 4, doi:10.3389/fimmu.2013.00319.
46. Lee, P.Y.; Kumagai, Y.; Li, Y.; Takeuchi, O.; Yoshida, H.; Weinstein, J.; Kellner, E.S.; Nacionales, D.; Barker, T.; Kelly-Scumpia, K. TLR7-dependent and FCgammaR-independent production of type I interferon in experimental mouse lupus. J. Exp. Med. 2008, 205, 2995–3006.
47. Subramanian, S.; Tus, K.; Li, Q.-Z.; Wang, A.; Tian, X.-H.; Zhou, J.; Liang, C.; Bartov, G.; McDaniel, L.D.; Zhou, X.J., et al. A TLR7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 2006, 103, 9970–9975.
48. Han, G.; Chen, S.; Shen, N.; Ye, S.; Bao, C.; Gu, Y. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 2003, 4, 177–186.
49. Barber, G.N. Sting-dependent cytosolic DNA sensing pathways. Trends Immunol. 2014, 35, 88–93.
50. Crow, Y.J.; Hayward, B.E.; Parmar, R.; Robins, P.; Leitch, A.; Ali, M.; Black, D.N.; van Bokhoven, H.; Brunner, H.G.; Hamel, B.C., et al. Mutations in the gene encoding the 3'–5' DNA exonuclease TREX1 cause aicardi-goutieres syndrome at the AGS1 locus. Nat. Genet. 2006, 38, 917–920.
51. Stetson, D.B.; Ko, J.S.; Heidmann, T.; Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134, 587–598.
52. Gall, A.; Treuting, P.; Elkon, K.B.; Loo, Y.-M.; Gale Jr, M.; Barber, G.N.; Stetson, D.B. Autoimmunity initiates in non-hematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012, 36, 120.
53. Taganov, K.D.; Boldin, M.P.; Chang, K.-J.; Baltimore, D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103, 12481–12486.
54. Hou, J.; Wang, P.; Lin, L.; Liu, X.; Ma, F.; An, H.; Wang, Z.; Cao, X. MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 2009, 183, 2150–2158.
55. Tang, Y.; Luo, X.; Cui, H.; Ni, X.; Yuan, M.; Guo, Y.; Huang, X.; Zhou, H.; de Vries, N.; Tak, P.P. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheumatol. 2009, 60, 1065–1075.
56. Luo, X.; Yang, W.; Ye, D.-Q.; Cui, H.; Zhang, Y.; Hirankarn, N.; Qian, X.; Tang, Y.; Lau, Y.L.; de Vries, N., et al. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 2011, 7, e1002128.
57. Tang, B.; Xiao, B.; Liu, Z.; Li, N.; Zhu, E.D.; Li, B.S.; Xie, Q.H.; Zhuang, Y.; Zou, Q.M.; Mao, X.H. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett. 2010, 584, 1481–1486.
58. Ceppi, M.; Pereira, P.M.; Dunand-Sauthier, I.; Barras, E.; Reith, W.; Santos, M.A.; Pierre, P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 2009, 106, 2735–2740.
59. Wang, P.; Hou, J.; Lin, L.; Wang, C.; Liu, X.; Li, D.; Ma, F.; Wang, Z.; Cao, X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 2010, 185, 6226–6233.
60. Zhou, H.; Huang, X.; Cui, H.; Luo, X.; Tang, Y.; Chen, S.; Wu, L.; Shen, N. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 2010, 116, 5885–5894.
61. Gilliet, M.; Cao, W.; Liu, Y.-J. Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8, 594–606.
62. Rowland, S.L.; Riggs, J.M.; Gilfillan, S.; Bugatti, M.; Vermi, W.; Kolbeck, R.; Unanue, E.R.; Sanjuan, M.A.; Colonna, M. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 2014, 211, 1977–1991.
63. Deng, Y.; Zhao, J.; Sakurai, D.; Kaufman, K.M.; Edberg, J.C.; Kimberly, R.P.; Kamen, D.L.; Gilkeson, G.S.; Jacob, C.O.; Scofield, R.H., et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet. 2013, 9, e1003336.
64. Kim, S.J.; Gregersen, P.K.; Diamond, B. Regulation of dendritic cell activation by microRNA let-7c and blimp 1. J. Clin. Investig. 2013, 123, 823–833.
65. Chafin, C.B.; Regna, N.L.; Dai, R.; Caudell, D.L.; Reilly, C.M. MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro. Autoimmunity 2013, 46, 351–362.
66. Crispin, J.C.; Kyttaris, V.C.; Terhorst, C.; Tsokos, G.C. T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 2010, 6, 317–325.
67. Coca, A.; Sanz, I. Updates on B-cell immunotherapies for systemic lupus erythematosus and sjogren’s syndrome. Curr. Opin. Rheumatol. 2012, 24, 451–456.
68. Pugh-Bernard, A.E.; Cambier, J.C. B cell receptor signaling in human systemic lupus erythematosus. Curr. Opin. Rheumatol. 2006, 18, 451–455.
69. Liu, Z.; Davidson, A. Baff and selection of autoreactive B cells. Trends Immunol. 2011, 32, 388–394.
70. Richardson, B.; Scheinbart, L.; Strahler, J.; Gross, L.; Hanash, S.; Johnson, M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheumatol. 1990, 33, 1665–1673.
71. Pan, W.; Zhu, S.; Yuan, M.; Cui, H.; Wang, L.; Luo, X.; Li, J.; Zhou, H.; Tang, Y.; Shen, N. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 2010, 184, 6773–6781.
72. Ballestar, E.; Esteller, M.; Richardson, B.C. The epigenetic face of systemic lupus erythematosus. J. Immunol. 2006, 176, 7143–7147.
73. Zhao, S.; Wang, Y.; Liang, Y.; Zhao, M.; Long, H.; Ding, S.; Yin, H.; Lu, Q. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheumatol. 2011, 63, 1376–1386.
74. Qin, H.; Zhu, X.; Liang, J.; Wu, J.; Yang, Y.; Wang, S.; Shi, W.; Xu, J. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J. Dermatol. Sci. 2013, 69, 61–67.
75. Alcocer-Varela, J.; Alarcon-Segovia, D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Investig. 1982, 69, 1388.
76. Setoguchi, R.; Hori, S.; Takahashi, T.; Sakaguchi, S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by il-2 neutralization. J. Exp. Med. 2005, 201, 723–735.
77. Lu, M.M.; Wang, J.; Pan, H.F.; Chen, G.M.; Li, J.; Cen, H.; Feng, C.C.; Ye, D.Q. Increased serum RANTES in patients with systemic lupus erythematosus. Rheumatol. Int. 2012, 32, 1231–1233.
78. De Lema, G.P.; Maier, H.; Nieto, E.; Vielhauer, V.; Luckow, B.; Mampaso, F.; Schlöndorff, D. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 2001, 12, 1369–1382.
79. Crispin, J.C.; Tsokos, G.C. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun. Rev. 2009, 8, 190–195.
80. Fan, W.; Liang, D.; Tang, Y.; Qu, B.; Cui, H.; Luo, X.; Huang, X.; Chen, S.; Higgs, B.W.; Jallal, B. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in t cells from patients with systemic lupus erythematosus. Arthritis Rheumatol. 2012, 64, 3715–3725.
81. Zhao, X.; Tang, Y.; Qu, B.; Cui, H.; Wang, S.; Wang, L.; Luo, X.; Huang, X.; Li, J.; Chen, S. MicroRNA-125A contributes to elevated inflammatory chemokine rantes levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheumatol. 2010, 62, 3425–3435.
82. Grammer, A.C.; Slota, R.; Fischer, R.; Gur, H.; Girschick, H.; Yarboro, C.; Illei, G.G.; Lipsky, P.E. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Investig. 2003, 112, 1506–1520.
83. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011, 29, 621–663.
84. Xiao, C.; Srinivasan, L.; Calado, D.P.; Patterson, H.C.; Zhang, B.; Wang, J.; Henderson, J.M.; Kutok, J.L.; Rajewsky, K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17–92 expression in lymphocytes. Nat. Immunol. 2008, 9, 405–414.
85. Baumjohann, D.; Kageyama, R.; Clingan, J.M.; Morar, M.M.; Patel, S.; de Kouchkovsky, D.; Bannard, O.; Bluestone, J.A.; Matloubian, M.; Ansel, K.M. et al. The microRNA cluster miR-17(sim)92 promotes tfh cell differentiation and represses subset-inappropriate gene expression. Nat. Immunol. 2013, 14, 840–848.
86. Kang, S.G.; Liu, W.-H.; Lu, P.; Jin, H.Y.; Lim, H.W.; Shepherd, J.; Fremgen, D.; Verdin, E.; Oldstone, M.B.A.; Qi, H. et al. MicroRNAs of the miR-17(SIM)92 family are critical regulators of TFH differentiation. Nat. Immunol. 2013, 14, 849–857.
87. Liu, Y.; Dong, J.; Mu, R.; Gao, Y.; Tan, X.; Li, Y.; Li, Z.; Yang, G. MicroRNA-30Apromotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheumatol. 2013, 65, 1603–1611.
88. Kotake, S.; Udagawa, N.; Takahashi, N.; Matsuzaki, K.; Itoh, K.; Ishiyama, S.; Saito, S.; Inoue, K.; Kamatani, N.; Gillespie, M.T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Investig. 1999, 103, 1345–1352.
89. Komiyama, Y.; Nakae, S.; Matsuki, T.; Nambu, A.; Ishigame, H.; Kakuta, S.; Sudo, K.; Iwakura, Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177, 566–573.
90. Wong, C.; Ho, C.Y.; Li, E.; Lam, C. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000, 9, 589–593.
91. Zhu, S.; Pan, W.; Song, X.; Liu, Y.; Shao, X.; Tang, Y.; Liang, D.; He, D.; Wang, H.; Liu, W.; et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat. Med. 2012, 18, 1077–1086.
92. Cameron, J.S. Lupus nephritis. J. Am. Soc. Nephrol. 1999, 10, 413–424.
93. Dai, Y.; Sui, W.; Lan, H.; Yan, Q.; Huang, H.; Huang, Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol. Int. 2009, 29, 749–754.
94. Zhou, H.; Hasni, S.A.; Perez, P.; Tandon, M.; Jang, S.I.; Zheng, C.; Kopp, J.B.; Austin, H., 3rd; Balow, J.E.; Alevizos, I. et al. MiR-150 promotes renal fibrosis in lupus nephritis by downregulating socs 1. J. Am. Soc. Nephrol. JASN 2013, 24, 1073–1087.
95. Liu, C.-C.; Kao, A.H.; Manzi, S.; Ahearn, J.M. Biomarkers in systemic lupus erythematosus: Challenges and prospects for the future. Ther. Adv. Musculoskelet. Dis. 2013, 5, 210–233.
96. Stagakis, E.; Bertsias, G.; Verginis, P.; Nakou, M.; Hatziapostolou, M.; Kritikos, H.; Iliopoulos, D.; Boumpas, D.T. Identification of novel microrna signatures linked to human lupus disease activity and pathogenesis: MiR-21 regulates aberrant t cell responses through regulation of pdcd4 expression. Ann. Rheum. Dis. 2011, 70, 1496–1506.
97. Sui, W.; Liu, F.; Chen, J.; Ou, M.; Dai, Y. Microarray technology for analysis of microrna expression in renal biopsies of lupus nephritis patients. Methods Mol. Biol. 2014, 1134, 211–220.
98. Chauhan, S.K.; Singh, V.V.; Rai, R.; Rai, M.; Rai, G. Differential microrna profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities. J. Clin. Immunol. 2014, 34, 491–503.
99. Te, J.L.; Dozmorov, I.M.; Guthridge, J.M.; Nguyen, K.L.; Cavett, J.W.; Kelly, J.A.; Bruner, G.R.; Harley, J.B.; Ojwang, J.O. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 2010, 5, e10344.
100. Kosaka, N.; Iguchi, H.; Ochiya, T. Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010, 101, 2087–2092.
101. Wang, G.-K.; Zhu, J.-Q.; Zhang, J.-T.; Li, Q.; Li, Y.; He, J.; Qin, Y.-W.; Jing, Q. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 2010, 31, 659–666.
102. Wang, G.; Tam, L.; Li, E.; Kwan, B.; Chow, K.; Luk, C.; Li, P.; Szeto, C. Serum and urinary free microrna level in patients with systemic lupus erythematosus. Lupus 2011, 20, 493–500.
103. Carlsen, A.L.; Schetter, A.J.; Nielsen, C.T.; Lood, C.; Knudsen, S.; Voss, A.; Harris, C.C.; Hellmark, T.; Segelmark, M.; Jacobsen, S. et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheumatol. 2013, 65, 1324–1334.
104. Chen, W.; Tan, K.; Huang, J.; Yu, X.; Peng, W.; Chen, Y.; Lin, X.; Chen, D.; Dai, Y. Analysis of microRNAs in patients with systemic lupus erythematosus, using solexa deep sequencing. Connect. Tissue Res. 2014, 55, 187–196.
105. Tang, Q.; Yang, Y.; Zhao, M.; Liang, G.; Wu, H.; Liu, Q.; Xie, Y.; Li, D.; Dai, Y.; Yung, S. et al. Mycophenolic acid upregulates miR-142–3P/5P and miR-146a in lupus CD4+ T cells. Lupus 2015, doi:10.1177/0961203315570685
106. Thai, T.-H.; Calado, D.P.; Casola, S.; Ansel, K.M.; Xiao, C.; Xue, Y.; Murphy, A.; Frendewey, D.; Valenzuela, D.; Kutok, J.L. et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316, 604–608.
107. Vigorito, E.; Perks, K.L.; Abreu-Goodger, C.; Bunting, S.; Xiang, Z.; Kohlhaas, S.; Das, P.P.; Miska, E.A.; Rodriguez, A.; Bradley, A. et al. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007, 27, 847–859.
108. Thai, T.H.; Patterson, H.C.; Pham, D.H.; Kis-Toth, K.; Kaminski, D.A.; Tsokos, G.C. Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the fas(lpr) mouse. Proc. Natl. Acad. Sci. USA 2013, 110, 20194–20199.
109. Zhou, S.Y.; Liang, D.; Huang, X.F.; Xiao, C.Y.; Tang, Y.J.; Jia, Q.; Harley, J.B.; Shen, N. In vivo therapeutic success of microRNA-155 (miR-155) antagomir in a mouse model of lupus pulmonary hemorrhage. Arthritis Rheumatol. 2013, 65, S246–S247.
110. Lashine, Y.A.; Salah, S.; Aboelenein, H.R.; Abdelaziz, A.I. Correcting the expression of miRNA-155 represses PP2AC and enhances the release of IL-2 in pbmcs of juvenile SLE patients. Lupus 2015, 24, 240–247.
111. Garchow, B.G.; Bartulos Encinas, O.; Leung, Y.T.; Tsao, P.Y.; Eisenberg, R.A.; Caricchio, R.; Obad, S.; Petri, A.; Kauppinen, S.; Kiriakidou, M. Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol. Med. 2011, 3, 605–615.
112. Lu, L.-F.; Boldin, M.P.; Chaudhry, A.; Lin, L.-L.; Taganov, K.D.; Hanada, T.; Yoshimura, A.; Baltimore, D.; Rudensky, A.Y. Function of miR-146a in controlling TREG cell-mediated regulation of TH1 responses. Cell 2010, 142, 914–929.
113. Boldin, M.P.; Taganov, K.D.; Rao, D.S.; Yang, L.; Zhao, J.L.; Kalwani, M.; Garcia-Flores, Y.; Luong, M.; Devrekanli, A.; Xu, J. MiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 2011, 208, 1189–1201.
114. Liang, D.; Zhou, S.Y.; Liu, Z.; Shan, Z.Y.; Brohawn, P.; Yao, Y.H.; Harley, J.B.; Shen, N. In vivo administration of miR-146a protects C57BL/6 mice from pristane-induced pulmonary hemorrhage via suppressing type i interferon response. Arthritis Rheumatol. 2013, 65, S1162–S1162.
115. Van Rooij, E.; Purcell, A.L.; Levin, A.A. Developing microRNA therapeutics. Circ. Res. 2012, 110, 496–507.